Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM

Publisher Name :
Date: 01-Apr-2017
No. of pages: 77
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023.

Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary tract and loss of bladder control resulting in leakage of urine. Embarrassment, isolation, and depression are observed among patients with Urinary Incontinence. Millions of individuals worldwide are suffering from Urinary Incontinence. It is most common among the old people. It increases the chances of developing several medical conditions such as local skin irritation, rashes, and urinary infections.

According to DelveInsight, the market size for Urinary Incontinence of 7 MM is estimated to be USD XX Million by 2023 at a CAGR of 9.5% for the forecast period i.e., 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

The report will help in developing business strategies by understanding the trends shaping and driving the Urinary Incontinence market.

Organize sales and marketing efforts by identifying the best opportunities for Urinary Incontinence in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the 7MM market of Urinary Incontinence and Insightful review of the key market drivers and barriers.

To understand the regulatory scenario in major markets.

The Report also covers the detailed historical and forecasted Urinary Incontinence market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM

Table of Contents

Report Introduction
Urinary Incontinence Market Overview at a Glance
7 MM Market Size of Urinary Incontinence (2013-2023)
Total Market Share Distribution of Urinary Incontinence for 7 MM in 2016
Total Market Share Distribution of Urinary Incontinence for 7 MM in 2023
Urinary Incontinence
Overview
Pathophysiology
Etiology
Risk factors
Diagnosis
Treatment
Epidemiology and Patient Population
Total number of Prevalent cases - 7MM Countries - (2016 & 2023)
Secondary Studies referred
United States
Prevalent Cases of Urinary Incontinence in United States
Percentage Distribution ofUrinary Incontinence by Sub Types
Germany
Prevalent Cases of Urinary Incontinence in Germany
Percentage Distribution ofUrinary Incontinence by Sub Types
France
Prevalent Cases of Urinary Incontinence in France
Percentage Distribution ofUrinary Incontinence by Sub Types
United Kingdom
Prevalent Cases of Urinary Incontinence in United Kingdom
Percentage Distribution ofUrinary Incontinence by Sub Types
Spain
Prevalent Cases of Urinary Incontinence in Spain
Percentage Distribution ofUrinary Incontinence by Sub Types
Italy
Prevalent Cases of Urinary Incontinence in Italy
Percentage Distribution ofUrinary Incontinence by Sub Types
Japan
Prevalent Cases of Urinary Incontinence in Japan
Percentage Distribution ofUrinary Incontinence by Sub Types
Treatment Algorithm
Current Unmet Needs
Marketed Drugs
Major Marketed Drugs
Myrbetriq\ Betmiga\Betani
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Botox
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Toviaz
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
VESIcare
Description
Regulatory Milestones
Advantages and Disadvantages
Product Profile
Efficacy
Safety
Side effects
Emerging Therapies
Key Emerging Therapies
Vibegron: Kissei Pharmaceutical Co., Ltd.
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
AbobotulinumtoxinA: Ipsen Group
Clinical Development
Product Profile
Clinical Trial by Phase
Mirabegron+Solifenacin: Astellas Pharma Inc.
Product Development Activities
Clinical Development
Product Profile
Clinical Trial by Phase
Global Urinary Incontinence: Country-Wise Market Analysis
Overview on Total Urinary Incontinence Market (2016)
Overview on Total Urinary Incontinence Market (2023)
Global Urinary incontinence: Market Analysis
United States Market Size
Europe Market Size
Germany Market Size
France Market Size
United Kingdom Market Size
Spain Market Size
Italy Market Size
Japan Market Size
Market Drivers
Market Barriers
Report Methodology
Consulting Services
Disclaimer
About DelveInsight



List of Tables

Table 1: 7 MM Market Size of Urinary Incontinence in USD Million (2013-2023)
Table 2: Prevalent Cases Urinary Incontinence in United States (2013-2023)
Table 3: Percentage Distribution of Urinary Incontinence by Sub Types in United States (2016)
Table 4: Prevalent Cases Urinary Incontinence in Germany (2013-2023)
Table 5: Percentage Distribution of Urinary Incontinence by Sub Types in Germany (2016)
Table 6: Prevalent Cases Urinary Incontinence in France (2013-2023)
Table 7: Percentage Distribution of Urinary Incontinence by Sub Types in France (2016)
Table 8: Prevalent Cases Urinary Incontinence in United Kingdom (2013-2023)
Table 9: Percentage Distribution of Urinary Incontinence by Sub Types in United Kingdom (2016)
Table 10: Prevalent Cases Urinary Incontinence in Spain (2013-2023)
Table 11: Percentage Distribution of Urinary Incontinence by Sub Types in Spain (2016)
Table 12: Prevalent Cases Urinary Incontinence in Italy (2013-2023)
Table 13: Percentage Distribution of Urinary Incontinence by Sub Types in Italy (2016)
Table 14: Prevalent Cases Urinary Incontinence in Japan (2013-2023)
Table 15: Percentage Distribution of Urinary Incontinence by Sub Types in Japan (2016)
Table 16: Marketed Drugs for Urinary Incontinence
Table 17: Emerging Therapies for Urinary Incontinence
Table 18: Total Urinary Incontinence , Distribution share (2016) as per the 7MM
Table 19: Total Urinary Incontinence , Distribution share (2023) as per the 7MM
Table 20: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 21: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 22: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 23: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 24: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 25: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
Table 26: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)


List of Figures

Figure 1:Types of Urinary Incontinence
Figure 2:Risk Factors of Urinary Incontinence
Figure 3:Treatment of Urinary Incontinence
Figure 4: Prevalent Cases of Urinary Incontinence in United States (2013-2023)
Figure 5: Percentage Distribution ofUrinary Incontinence by Sub Types in United States (2016)
Figure 6: Prevalent Cases of Urinary Incontinence in Germany (2013-2023)
Figure 7: Percentage Distribution ofUrinary Incontinence by Sub Types in Germany (2016)
Figure 8: Prevalent Cases of Urinary Incontinence in France (2013-2023)
Figure 9: Percentage Distribution ofUrinary Incontinence by Sub Types in France (2016)
Figure 10: Prevalent Cases of Urinary Incontinence in United Kingdom (2013-2023)
Figure 11: Percentage Distribution ofUrinary Incontinence by Sub Types in United Kingdom (2016)
Figure 12: Prevalent Cases of Urinary Incontinence in Spain (2013-2023)
Figure 13: Percentage Distribution ofUrinary Incontinence by Sub Types in Spain (2016)
Figure 14: Prevalent Cases of Urinary Incontinence in Italy (2013-2023)
Figure 15: Percentage Distribution ofUrinary Incontinence by Sub Types in Italy (2016)
Figure 16: Prevalent Cases of Urinary Incontinence in Japan (2013-2023)
Figure 17: Percentage Distribution ofUrinary Incontinence by Sub Types in Japan (2016)
Figure 18:Treatment algorithm for Children with Urinary Incontinence
Figure 19:Treatment algorithm for Men with Urinary Incontinence
Figure 20:Treatment algorithm for Women with Urinary Incontinence
Figure 21: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2016)
Figure 22: Total 7 Major Market Size of Urinary Incontinence in USD, Million (2023)
Figure 23: United States Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 24: Germany Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 25: France Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 26: United Kingdom Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 27: Spain Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 28: Italy Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 29: Japan Market Size of Urinary Incontinence in USD, Million (2013-2023)
Figure 30: Market Drivers for Urinary Incontinence
Figure 31: Market Barriers for Urinary Incontinence
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Overactive Bladder - Pipeline Review, H1 2017
    Published: 09-May-2017        Price: US 2000 Onwards        Pages: 114
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H1 2017, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urin......
  • Interstitial Cystitis - Pipeline Review, H1 2017
    Published: 28-Apr-2017        Price: US 2000 Onwards        Pages: 82
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides an overview of the Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline landscape. Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladd......
  • Interstitial Cystitis - Epidemiology Insights -2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's "Interstitial Cystitis - Epidemiology Insights -2023" Reports provides an overview of the disease. The Report includes global forecast of epidemiology of Interstitial Cystitis till 2023. Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems. Current studies estimate tha......
  • Urinary Incontinence - Epidemiology Forecast To 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's Urinary Incontinence - Epidemiology Forecast To 2023" Reports provides an overview of the disease and epidemiology trends of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary......
  • Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 73
    DelveInsight's "Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Interstitial Cystitis for the seven major markets i.e. United States, Europe (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue, treatment practice and Interstitial Cystitis forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report also inc......
  • Pyelonephritis - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 58
    Pyelonephritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Pipeline Review, H1 2017, provides an overview of the Pyelonephritis (Infectious Disease) pipeline landscape. Pyelonephritis is a specific type of urinary tract infection (UTI) that generally begins in urethra or bladder and travels up into kidneys. Signs and symptoms include fever, abdominal pain, freque......
  • Nocturia - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H1 2017, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape.Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping d......
  • Urinary Incontinence - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 66
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk factors includ......
  • Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Interstitial Cystitis (Painful Bladder Syndrome) Report is to understand the market and pipeline status of the drugs around the Interstitial Cystitis (Painful Bladder Syndrome) to explore th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs